NDC properties for NDC 9 0051-8450
NDC item 00051845001
| NDC 9 | 0051-8450 |
|---|---|
| NDC 10 | 0051-8450-01 |
| NDC Item | 00051845001 |
| packaging | 5 g in 1 PACKET |
| DCSA | CIII |
| FDA SPL set id | 697001 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2023-03-31 |
| Marketing effective time low | 2011-03-14 |
| Marketing status | COMPLETED |
| NDA | NDA021015 |
NDC item 00051845030
| NDC 9 | 0051-8450 |
|---|---|
| NDC 10 | 0051-8450-30 |
| NDC Item | 00051845030 |
| packaging | 30 PACKET in 1 CARTON (0051-8450-30) / 5 g in 1 PACKET (0051-8450-01) |
| DCSA | CIII |
| FDA SPL set id | 697001 |
| Labeler | AbbVie Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2023-03-31 |
| Marketing effective time low | 2011-03-14 |
| Marketing status | COMPLETED |
| NDA | NDA021015 |